Latest news with #DineshPatel
Time of India
6 days ago
- Time of India
Robbers loot drone cameras, held in Pratapgarh
Prayagraj: Neighbouring Pratapgarh cops on Monday claimed to have busted an inter-district gang of robbers targeting marriage ceremony photographers using drone cameras and arrested two of its key members near Umarpur turn while they were planning to sell the looted drone cameras. Tired of too many ads? go ad free now The police also seized two looted drone cameras, a charger, a remote, batteries, a bike, and one country-made pistol of Rs 315 bore along with two cartridges from their possession. The arrested robbers, identified as Raju Patel (23) and Dinesh Patel (27), are residents of Rampur Bela (Patti). The arrested robbers confessed to the police that there are a total of six members in their gang who used to target marriage photographers using drone cameras for shooting. The gang executed around half a dozen drone camera thefts in Pratapgarh and adjoining districts. Raju admitted to the police that his gang executed drone camera thefts at Kandhai and other areas on May 10, 23, and 26 at three different spots. The robbers also confessed that they used to target photographers using drone cameras once they returned from covering marriage ceremony events. As drone cameras and their accessories are quite expensive in the market, the gang's modus operandi was to target photographers. They used to connect with marriage parties and gather details of photographers assigned the task of coverage. Police said that three criminal cases each were pending against the arrested robbers. They were booked under section 310(2) and 317(2) of BNS and section 3/25 of the Arms Act. Teams are dispatched to ensure the arrest of other members of the gang.
Associated Press
21-05-2025
- Business
- Associated Press
Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025
NEWARK, CA / ACCESS Newswire / May 21, 2025 / Protagonist Therapeutics, Inc. ('Protagonist' or the 'Company') today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the Jefferies Global Healthcare Conference taking place June 3-5, 2025, in New York, NY. The Company will also participate in one-on-one meetings. Jefferies Global Healthcare Conference - June 3-5, 2025 Format: Company Presentation Day/Time: Wednesday, June 4 at 1:25 P.M. ET Webcast: If you are interested in meeting with the Protagonist team during the conference, please reach out to your Jefferies representative. A replay of the presentation will be available on the Company's Investor Relations Events and Presentations webpage for one year following the event. About Protagonist Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides, icotrokinra and rusfertide, derived from Protagonist's proprietary discovery platform are currently in advanced Phase 3 clinical development, with New Drug Application submissions to the FDA expected in 2025. Icotrokinra (JNJ-2113) is a first-in-class investigational targeted oral peptide that selectively blocks the Interleukin-23 receptor ('IL-23R') which is licensed to Janssen Biotech, Inc., a Johnson & Johnson company. Following icotrokinra's joint discovery by Protagonist and Johnson & Johnson scientists pursuant to the companies' IL-23R collaboration, Protagonist was primarily responsible for development of icotrokinra through Phase 1, with Johnson & Johnson assuming responsibility for development in Phase 2 and beyond. Rusfertide, a mimetic of the natural hormone hepcidin, is currently in Phase 3 development for the rare blood disorder polycythemia vera (PV). Rusfertide is being co-developed and will be co-commercialized with Takeda Pharmaceuticals pursuant to a worldwide collaboration and license agreement entered into in 2024 under which the Company remains primarily responsible for development through NDA filing. The Company also has a number of pre-clinical stage oral drug discovery programs addressing clinically and commercially validated targets, including the IL-17 oral peptide antagonist PN-881, an oral hepcidin program, and an oral obesity program. More information on Protagonist, its pipeline drug candidates and clinical studies can be found on the Company's website at Investor Relations Contact Corey Davis, Ph.D. LifeSci Advisors +1 212 915 2577 [email protected] Media Contact Virginia Amann, Founder/CEO +1 833 500 0061 ext 1 ENTENTE Network of Companies [email protected] SOURCE: Protagonist Therapeutics press release
Time of India
22-04-2025
- Time of India
Bengaluru businessman's luggage stolen on Gujarat train, Rs 11 lakh in valuables stolen
Ahmedabad: A 50-year-old businessman and his family, travelling from Bengaluru to Bhuj on a train, woke up in shock early on Tuesday to discover that three bags containing cash, gold, and silver jewellery worth around Rs 11 lakh had been stolen from their berth. Dinesh Patel, who lives in Bengaluru in Karnataka, and his 12 relatives discovered the theft between Nadiad and Chandlodia stations. According to the complaint filed with Sabarmati (railway) police on Tuesday, three bags containing cash, gold, silver jewellery, smartwatches and other items with an estimated total value of Rs 10.91 lakh were stolen while the passengers were asleep. The theft is believed to have occurred between 4.30am and 6.30am on Tuesday. The complainant noticed the missing bags on waking up. Police registered a case and are reviewing CCTV footage and passenger details for further investigation.
